• 1. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 5. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473

AG 1478 Hydrochloride: A Comprehensive Overview of Its Chemical Profile and Recent Research Applications

The compound with the CAS number 170449-18-0, known as AG 1478 Hydrochloride, represents a significant advancement in the field of pharmaceutical chemistry. This compound has garnered considerable attention due to its unique molecular structure and its potential applications in various therapeutic areas. AG 1478 Hydrochloride is a hydrochloride salt form of a synthetic molecule that has been extensively studied for its biological activity and pharmacological properties.

In recent years, the study of AG 1478 Hydrochloride has been further propelled by its role in preclinical and clinical research. Its molecular framework, characterized by specific functional groups, allows it to interact with biological targets in a manner that has been explored for potential therapeutic benefits. The hydrochloride form enhances the solubility and bioavailability of the compound, making it more suitable for formulation into pharmaceutical products.

One of the most compelling aspects of AG 1478 Hydrochloride is its observed efficacy in inhibiting specific kinases that are involved in cancer progression. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is often associated with various diseases, particularly cancer. The ability of AG 1478 Hydrochloride to modulate these pathways has made it a subject of intense interest among researchers.

Recent studies have demonstrated that AG 1478 Hydrochloride can selectively inhibit certain tyrosine kinases, which are overactive in many types of cancer. By targeting these kinases, the compound disrupts the abnormal signaling networks that drive tumor growth and metastasis. This selective inhibition is a critical factor in its potential as an anti-cancer agent. Moreover, the hydrochloride salt form contributes to improved pharmacokinetic properties, allowing for more effective drug delivery and action.

The chemical structure of AG 1478 Hydrochloride includes a central core that is modified with functional groups designed to enhance binding affinity to its target proteins. This structural design has been refined through computational modeling and experimental optimization to maximize its biological activity while minimizing off-target effects. Such precision in molecular design is a hallmark of modern drug development strategies.

Research into AG 1478 Hydrochloride has also explored its potential in treating other diseases beyond cancer. Its kinase-inhibiting properties have shown promise in conditions where abnormal cell proliferation is a key factor. For instance, studies have indicated that it may have applications in inflammatory diseases and autoimmune disorders by modulating inflammatory signaling pathways.

The synthesis of AG 1478 Hydrochloride involves multi-step organic reactions that require careful control of reaction conditions to ensure high yield and purity. Advanced synthetic methodologies have been employed to streamline the production process, making it more scalable for industrial applications. The hydrochloride salt form is particularly favored for its stability and ease of handling during formulation.

In clinical trials, AG 1478 Hydrochloride has been evaluated for its safety and efficacy in human subjects. Preliminary results have been encouraging, showing that it can be well-tolerated at therapeutic doses while exhibiting significant anti-cancer activity. These findings have prompted further investigation into its potential as a viable therapeutic option for patients with certain types of cancer.

The development of AG 1478 Hydrochloride exemplifies the intersection of chemistry, biology, and medicine in modern drug discovery. Its unique properties make it a valuable tool for researchers studying kinase-dependent diseases, offering new insights into potential treatment strategies. As research continues, the full therapeutic spectrum of this compound is expected to become clearer.

The future directions for AG 1478 Hydrochloride include exploring combination therapies with other drugs to enhance efficacy and reduce resistance. Additionally, efforts are underway to develop novel derivatives with improved pharmacological profiles. The versatility of this compound's chemical framework provides a strong foundation for such explorations.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)